NCT07022938

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

Efficacy and Safety of a Tablet Containing Palmitoyethanolamide, Alpha Lipoic Acid, Vitamin B12, Vitamin B6 , Vitamin B1, Nicotinamide, Magnesium, Zinc, Vitamin E, and Superoxide of Dismutase in Individuals Receiving Chemotherapy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Aristotle University Of Thessaloniki · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Administration of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy

Detailed description

Investigation of effectiveness and safety of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy

Conditions

• Cancer
• Neuropathy
• Chemotherapy Induced Pain Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Epineuron	Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nicotinamide (9 mg) and minerals (Mg 30 mg, Zn 2.5 mg) in one tablet
DIETARY_SUPPLEMENT	Placebo Tablets	placebo tablet without active ingredients

Timeline

• Start date: 2021-11-01
• Primary completion: 2025-01-31
• Completion: 2025-12-15
• First posted: 2025-06-15
• Last updated: 2025-12-26

Locations

1 site across 1 country: Greece